Specialty Drug Delivery Firm Integral BioSystems LLC Aims to Advance Eyedrop Technology

Boston area pharmaceutical formulation developer, Integral BioSystems LLC, wants to help others leverage Integral’s OcuSurf™ formulation platform.

OcuSurf™ can shorten the path from a new idea to a new product.”

— Dr. Shikha Barman

BEDFORD, MA, US, September 1, 2020 /EINPresswire.com/ — Integral BioSystems is offering drug developers “inside information” to help them utilize Integral’s innovative eyedrop development platform OcuSurf™.

The program aims to help 3 different types of client. First, for companies seeking to develop a new eyedrop product that is using a re-purposed drug, Integral offers its innovative delivery system as a licensable technology to build value into a prospective client’s drug products.

Second, for companies seeking product life cycle management, Integral can help to quickly ascertain if OcuSurf™ can provide the desired improvements. With multiple billion dollar drug products going off-patent, this is an excellent way to develop an extended product life cycle with novel IP. In this manner, Integral will offer its insight and technological innovation strategies to improve the customer’s product portfolio.

Finally, for companies wanting a drug formulation that includes both a new chemical entity and an innovative delivery system resulting in a highly efficacious formulation that will distinguish its eyedrop product in the crowded marketplace, Integral’s OcuSurf™ can offer new product development with a minimum of delay.

About Integral BioSystems
Integral BioSystems is a specialty drug delivery contract research organization that offers an integrated, practical approach to formulation development projects for both small molecule and large molecule drug candidates. Offering contract services to pharmaceutical companies to develop drug products through its CMC offerings in analytical method development, formulation development, process development, scale-up and technology transfer, the company also partners with pharmaceutical companies to co-develop products based on its proprietary pharmaceutical delivery systems.

The Company has developed numerous dosage forms for ophthalmic applications. Integral BioSystems has a translational approach to drug development, customizing delivery systems to achieve the biologically effective objectives of the therapy. Dosage forms are customized to achieve sustained release or targeted, tissue-focused delivery or fast-release/instant delivery, depending upon the desired product attributes.

Dave Karasic
Integral BioSystems, LLC
+1 617-820-8483
email us here

Source: EIN Presswire

Landmark trial shows trained immunity reduces respiratory infections in the elderly by 80%

LUXEMBOURG, September 1, 2020 /EINPresswire.com/ — Landmark trial shows trained immunity reduces respiratory infections in the elderly by 80%

Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Therapeutics, notes the results of a clinical trial (1) (“the Trial”) published in Cell showing that trained immunity through the use of BCG vaccination can reduce respiratory tract infections by 80% amongst elderly people including, potentially, COVID-19.

The Trial provides further evidence that BCG induces trained immunity responses and validates the approach followed by TTxD which uses advanced bioengineering methods to produce nanobiologic therapeutics based upon components of the BCG vaccine.

The Trial was coordinated by Mihai G. Netea, founder and Chair of TTxD’s scientific advisory board and Professor of Experimental Internal Medicine at Radboud UMC. The Trial was a collaboration between the University of Athens Medical School, Radboud University Medical Center and the Life & Medical Sciences Institute, University of Bonn.

Various studies have shown that BCG vaccination can control the production of cytokines by the immune system to provide non-specific beneficial effects against infections. TTxD’s proprietary platform technology is based on over a decade of research and development (2).

Under an exclusive license from the Icahn School of Medicine at Mount Sinai in New York and Radboud University Medical Center in the Netherlands, TTxD applies advanced bioengineering methods to develop nanobiologic therapeutics based upon the BCG vaccine. Nanobiologics are materials constructed from molecular building blocks that our body produces naturally. The advantage of this approach is that nanobiologic therapy modulates natural mechanisms to regulate the innate immune system with materials that are inherently well tolerated by the body.

Commenting on the Trial, Mihai Netea, MD, PhD co-founder of TTxD said: “The trials show a significant reduction of respiratory tract infections in people vaccinated with BCG and add to TTxD’s growing scientific evidence that trained immunity can play an important role in fighting the world’s most lethal diseases and saving lives.”

Leighton Durham, Co-Chief Executive Officer of TTxD said: “The scientific team at TTxD identified the potential of the body’s innate immune system to be effective in a number of clinical settings through the process now known as trained immunity. Today’s news is proof that trained immunity could be effective against COVID-19 infection and dramatically improves the health of elderly patients. We are delighted that this news builds on the team’s track record of trained immunity studies in infectious diseases, oncology and organ transplantation.”

1. The BCG Vaccination Protects Against Infections In The Elderly: The Activate Double-Blind Randomized Trial
2. www.nature.com/articles/s41573-019-0025-4


For more information please contact:
Audrey Richardson
Jean Boulle Medtech
+352 222 512

Media inquiries:
Michael Oke/Andy Mills
Aura Financial
+44 207 321 0000

Notes to Editors:

TTxD https://ttxdiscovery.com/

TTxD’s proprietary platform technology is based on over a decade of research and development. Using bioengineering methods, TTxD produces nanobiologic therapeutics that can induce an immune response against tumors or dampen hyperinflammation after organ transplantation. TTxD has an established library of nanobiologic therapeutics relevant to many potentially fatal diseases, including Acute Respiratory Distress Syndrome.

Traditionally, it has been assumed that immunological memory is exclusively located in our adaptive immune system. Pioneering work from TTxD founders Mihai Netea and Leo Joosten has revealed that the innate immune systems also has adaptive characteristics. This de facto innate immune memory is called ‘trained immunity’.

Jean Boulle Therapeutics www.boulletherapeutics.com

Boulle Therapeutics, part of the Jean Boulle Group, is a long-term investor in novel techniques for treating harmful diseases. Boulle Therapeutics identifies, invests in, and supports the development of early, seed stage innovations that have the potential to save lives and improve the quality of life for large numbers of people. Boulle Therapeutics works closely with a range of investors and other partners who share its approach to the development of early stage technologies.

Radboud University https://www.radboudumc.nl/en/patient-care

Radboud University have today issued the following press release relating to the publication by Cell: https://www.radboudumc.nl/en/news-and-media

Michael Oke/Andy Mills
Trained Therapeutix Discovery
+44 20 7321 0000
email us here

Source: EIN Presswire

Mursla raises £0.5M funding to progress development of its exosome-based novel technology platform for cancer detection

The Mursla Team outside their labs at Cambridge Science Park

The Mursla Team outside their labs at Cambridge Science Park

Pierre Arsène, Founder & CEO, Mursla

Pierre Arsène, Founder & CEO, Mursla

The additional funding is a mark of confidence in our strategy from both the UK government and our existing investors in this currently challenging environment.”

— Pierre Arsène, Founder & CEO, Mursla

CAMBRIDGE, UK, September 1, 2020 /EINPresswire.com/ — Mursla, a liquid biopsy company, has raised £410K from the UK Government’s Future Fund and existing investors. In addition, the organisation has secured a £40K COVID-19 grant from the Cambridgeshire Capital Grant Scheme.

The funding will enable Mursla to finalise its work on its novel exosome-based liquid biopsy platform, ExoPheno(TM), with the aim of demonstrating how the platform can detect cancer signatures in plasma from solid tumours via exosomes.

Exosomes are heterogeneous vesicles naturally released by all cells during their lives, especially tumour cells, and usually carry biologically active molecules that can deliver their messages to local or distant targets.

A cancer liquid biopsy is a test undertaken on a blood sample to look for tumour information, including from nucleic acids or proteins, that is circulating in the blood. Much less invasive and heterogeneous than traditional biopsies, which require local anesthesia and often cause discomfort to the patient, this simple blood draw could routinely offer life-saving early cancer detection or help monitor tumours during and after treatments.

The liquid biopsy space has seen tremendous progress over the last five years, as evidenced by the first FDA approval for cancer liquid biopsy via nucleic acid sequencing as a companion diagnostic in August this year. However, due to its lack of sensitivity, this route failed to demonstrate game-changing early cancer detection. Mursla’s novel approach could provide the solution to this problem.

Mursla has also recently relocated from its roots at the Cavendish Laboratory at the University of Cambridge to its own laboratory and office space at the Cambridge Science Park.

Pierre Arsène, Founder & CEO, Mursla commented: “The additional funding is a mark of confidence in our strategy from both the UK government and our existing investors in this currently challenging environment. It has allowed us to make up for lost time during lockdown and expedited our move to fully equipped lab space at Cambridge Science Park, which has been an extremely positive step forward.

“Our next goal is to find VC partners to help us scale our assays and validate our own exosome-based biomarker panel for liver cancer detection.”

As Mursla approaches significant milestones in the development of its platform, the company aims to raise its Series-A by the end of this year.

Notes to Editors

About Mursla
Mursla is a Cambridge-based liquid biopsy company based on a novel liquid biopsy platform which traces diseases in biofluids via exosomes. Exosomes (also known as Extracellular Vesicles) are emerging biomarkers widely regarded as one of the most promising for cancer diagnostics and other diseases. Using quantum biology, nanotechnology and bioengineering, Mursla is developing its platform to detect dozens of cancer types with a single blood test.

Discover more: https://www.mursla.com

About the Future Fund
The Future Fund was established by the Chancellor of the Exchequer to support the UK’s most innovative businesses demonstrating high growth potential and currently affected by COVID-19. The Fund provides government loans to UK-based companies ranging from £125,000 to £5 million, subject to at least equal match funding from private investors. These convertible loans may be an option for businesses that rely on equity investment and are unable to access other government business support programmes because they are either pre-revenue or pre-profit.

Find out more: https://www.gov.uk/guidance/future-fund

Sarah Brereton
+44 7796 583223
email us here

Source: EIN Presswire

Corporate Wellness Market with COVID-19 Impact Analysis 2026 | ComPsych Corporation, Central Corporate Wellness

Global corporate wellness market is growing at a steady pace, with increase in penetration of corporate wellness services, due to increasing health care costs.

ALBANY, NEW YORK, UNITED STATES, August 31, 2020 /EINPresswire.com/ — Employee welfare is gaining center-stage as across countries, governments demand it and companies witness benefits accrue on account of better employee well-being. Not only do such programs and initiatives help improve emotional and physical health of a large segment of population but also they help in improving work performance.

As per Transparency Market Research, “The global corporate wellness market is on an upward curve and a number of interesting growth opportunities are anticipated to emerge over the forecast period particularly for large MNCs and corporate houses that are already involved in such initiatives. It is expected that areas such as healthcare, individual needs, and insurance will be hotbeds.”

One of the most significant areas that are expected to drive the market on to a higher growth trajectory over the forecast period is health risk assessment. It holds a special place in the overall growth story owing to being one of the most needed elements in terms of well-being. Besides, it allows for better work output if the employees are in the best of their health.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4743

A number of schemes that are seeing an increase in implementation are smoking cessation, nutritional advice, fitness drills, health screening, and weight management. Governments across the globe have been quite emphatic in their push towards improvement in health and wellness. They have also pushed for better safety and hygiene of employees.

Transparency Market Research states that the over the forecast period global corporate wellness market would grow by a rate of 8.8%, compounded annually over the period 2018 to 2026. A number of companies are working towards improving their performance index by improving work and efforts directed towards such corporate wellness programs, driving the market forward by a substantial value. It is also worth noting that the North America would hold a prominent place in the regional charts with a sizeable revenue accounted for by the region.

Request for Analysis of COVID19 Impact on Corporate Wellness Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4743

Asia Pacific Region to Chart Notable Growth in the Global Corporate Wellness Market over the Forecast Period

A number of companies in the global corporate wellness market are now eyeing the Asia Pacific (APAC) region owing to factors such as anticipation regarding higher growth rate, leading to a number of untapped growth opportunities. In order to understand what is driving the region o remarkable growth, it is significant to understand that a lot of Foreign Direct Investment is pouring in the region. Intellectual resources are also making their way in the market. Thus one notes an increase in training modules, welfare schemes and healthcare guidelines. Besides, there is push from employees and the government to put such safeguards in place.

It is also worth noting here that a sizeable share of revenue will be accounted for by regions such as North America and Europe, which are developed, and implemented such schemes way back, and are now ready to capitalize upon that move. Presence of strong players in the two regions is also a significant factor, propelling growth in the market.

Buy Corporate Wellness Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=4743&ltype=S

Fragmented and Competitive – Vendor Landscape of Global Corporate Wellness Explained

The global corporate wellness market is fragmented and leading players include ComPsych Corporation, Central Corporate Wellness, Optum, Inc., Truworth Wellness, SOL Wellness, JLT Australia (Recovre Group), Sodexo, and ConneXions Asia.Market players are contributing positively to the growth of global corporate wellness market by their proactive and creative measures taken up at regular intervals.

To consolidate market position and penetrate new markets, players often deploy strategies such as alliances – mergers and acquisitions, and partnerships and collaborations. As per Transparency Market Research, “These allow players to combine know-how, resources, and technology improvement. Besides, a firm grasp on the market can be achieved via strategic alliances based on mutual synergies.

Mr Rohit Bhisey
Transparency Market Research
+1 518-618-1030
email us here
Visit us on social media:

Source: EIN Presswire

Electronic Health Records (EHR) Market: Comprehensive Study Explores Huge Growth in Future

The global electronic health records market was valued at US$ 26,126.3 Mn in 2018 and is anticipated to expand at a CAGR of 4.8% from 2019 to 2027.

ALBANY, NEW YORK, UNITED STATES, August 31, 2020 /EINPresswire.com/ — Transparency Market Research (TMR) has published a new report titled, ‘Electronic Health Records Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global electronic health records market was valued at US$ 26,126.3 Mn in 2018 and is projected to expand at a CAGR of 4.8% from 2019 to 2027.


An electronic health record (EHR) system helps health care workers to record patient-related data electronically. Patient-related data may include demographics, medications, medical history, vital signs, diagnostic test results, and imaging reports.

An EHR system enables clinicians to offer improved patient care through automated access to information. EHR enhances patient care by reducing the incidence of medical error by improving the accuracy and clarity of medical records, reducing duplication of tests, reducing delays in treatment, thus helping patients to take better decisions related to their health.

Globally, the EHR market is witnessing rapid growth as a result of its increasing popularity among health care professionals. For instance, health care facilities with high budgets have been way ahead of small-size practices in adopting EHR systems. Over the past few years, small-size practices have been increasingly adopting web-based EHR systems, which come for little or no upfront cost and monthly rental facility.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4153

Government incentives propel rapid adoption of EHR systems across health care facilities

Governments of various countries encourage health care providers to adopt EHR systems by providing incentives. Financial incentives by governments would continue to drive the EHR market during the forecast period.

The Medicare Electronic Health Record (EHR) Incentive Program is governed by the Centers for Medicare & Medicaid Services (CMS), while the Medicaid EHR Incentive Program is managed by the state Medicaid agencies. The Medicare and Medicaid EHR Incentive Programs offer incentives to physicians, hospitals, and other health care facilities for meaningful use of certified EHR technology in the U.S. An eligible professional or hospital can receive a maximum incentive amount of up to US$ 44,000 through the Medicare EHR Incentive Program and up to US$ 63,750 through the Medicaid EHR Incentive Program. This incentive program succeeded in encouraging a large number of health care facilities to adopt EHR systems.

Similarly, in the U.K., as part of the NHS Digitization initiative, the U.K.’s Department of Health (DoH) allocated over US$ 6 Bn to NHS for the healthcare digitization in 2016; of which over US$ 2.6 Bn was allocated for movement of paper records to a centralized electronic record systems, in addition to the implementation of wireless technologies and addressing the cyber security concerns in NHS IT ecosystem

Request for Analysis of COVID19 Impact on Electronic Health Records (EHR) Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4153

Client Server Based Segment to Dominate Market

Based on installation type, the global electronic health records market has been divided into web-based, client server based, and software as service. The client server based segment, dominates the market in year 2018, attributable to its efficiency of storage of patient medical data and it widely stores a large amount of patient data. Moreover, in house IT teams offer priority to the data and client server based is more accessible than other server.

Software as services segment is estimated to propel at rapid pace during forecast period. Software as a service (SaaS) is gaining higher preference among physicians as it eliminates technological error and offer low upfront costs. Moreover, SaaS EHR vendors charge a monthly subscription fee that covers both the software cost and the cost of maintaining the remote server and updating the EHR. This is likely to augment the market of the segment in coming years.

North America to Dominate Global Market

In terms of region, the global electronic health records market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global electronic health records market in 2018, followed by Europe.

North America accounted for major share of the global electronic health records market in 2018, owing to increased governmental funding for EHR implementation. Technological advancements, governmental and private organizations’ initiatives to ensure EHR implementation across health care settings in North America is another propel factor for driving electronic health records market during the forecast period. Moreover, financial incentives by governments will continue to drive the EHR market in coming years.

The electronic health records market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to disease prevalence across region, unmet medical needs, implementation and technological advancements in electronic health records are some of the factors expected to drive the electronic health records market in Asia Pacific during the forecast period. Presence of a large pool of patients in the region makes Asia-Pacific a potential market for EHR, as health care providers need a large number of EHRs for effective patient care and services. This is likely to augment the growth of the electronic health records in Asia-Pacific market

Buy Electronic Health Records (EHR) Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=4153&ltype=S

Competitive Landscape

The global electronic health records market is consolidated in terms of number of players. Key players in the global market include AdvancedMD, Allscripts Healthcare, LLC and/or its affiliates, Cerner Corporation, DXC Technology Company, CureMD Healthcare, eClinicalWorks, GE Healthcare, Greenway Health, LLC, Healthcare Information Management Systems, McKesson Corporation, Athena Health Inc., and other prominent players.

Mr Rohit Bhisey
Transparency Market Research
+1 518-618-1030
email us here

Source: EIN Presswire

A Helping Hand from PSK: Safe, Sanitary, Hand Cream for Your Skin Protection

Herdsman Enterprises will be showcasing their new product, PSK Protect Hand Cream at various beauty and skincare related events in 2020.

The right cosmetics for every lady.”

— Herdsman Enterprise

TAIPEI, TAIWAN, September 1, 2020 /EINPresswire.com/ — To prevent COVID-19, most people use alcohol-based hand sanitizers that contain 75% alcohol to clean their hands. Due to its high volatility, it easily strips away moisture in the outer layer of skin and makes the skin dry, itchy and even allergic. In order to solve this problem, Herdsman Enterprises have decided to manufacture antibacterial moisturizing hand cream to enhance skin protection after using alcohol. The company will be showcasing their new product, PSK Protect Hand Cream at various beauty and skincare related events in 2020.

PSK Protect Hand Cream is like a pair of invisible gloves that provide integrated care to your hand all while enhancing skin protection. The product is ideal in strengthening and protecting skin from environmental hazardous substances. With its functions of fighting bacteria, soothing and brightening the skin, it is targeted to enhance the skin’s protection especially during the COVID-19 pandemic.Herdsman Enterprises is dedicated to providing high-quality products through strict product examination and qualification, and sees a vast business opportunity in the US, UK, and Southeast Asia.

Top Competitive Advantages:
• Anti-bacterial and disinfection properties for extra protection
• Nourish, repair,and improve skin condition in the long term
• Invigorate and moisten skin

About Herdsman Enterprises
Founded in 1973 and headquartered in Taipei, Taiwan, Herdsman Enterprise has developed a whole range of skincare and cosmetics products using patented and effective ingredients. The company insists on offering its customers the safest and non-irritating skin care experiences with a simple yet effective formula, avoiding any unnecessary ingredients in the products. Certified by FDA, EEC and SASO, the products have been sold in more than 30 countries.

For more information, please visit https://herdsman-cosmetic.com.
Additional Information:
Press Kit download: https://brand.sparkamplify.com/herdsman-enterprises
Facebook: https://www.facebook.com/pskskincareandmakeup/
LinkedIn: https://www.linkedin.com/company/psk-skincare-makeup/
Media contact: Joshua Sim
Email: huikeit.sim@beanne.com.tw
Phone: +886989070605

Joshua Sim
Herdsman Enterprise Co., Ltd.
+886 989 070 605
email us here
Visit us on social media:

Source: EIN Presswire

Weight Loss Buddy Releases Its' New Mobile Support App

New Weightlossbuddy Mobile App

weightlossbuddy Mobile App

Weight LOss Buddy Desktop Website

www.weightlossbuddy.com Desktop Website

Obesity is at epidemic proportions.

You can't help someone up a hill without getting closed the top yourself"”

— Joey Dweck

TENAFLY, NEW JERSEY, UNITED STATES, September 1, 2020 /EINPresswire.com/ — In its’ continuing battle against obesity, WeightLossBuddy.com has launched a brand new App.

A longtime leader in the field of health and wellness it has designed a social media app dedicated to helping people Lose Weight while adapting a healthier lifestyle.

In study after study, support from others has been proven to help people lose weight and keep it off.

It has long been known that emotions play a major role in overeating. For close to 20 years, Weight Loss Buddy has helped by offering emotional support through its’ “no questions asked policy” of encouraging people to help each other. Some 250,000 users later, weight Loss Buddy has provided a forum for those who want to lose weight, but do not know where to turn.

Joey Dweck, its’ founder, likes to emphasize not only the benefits of getting help from a Buddy(s), but just as important, offering help to others. In many cases, food is used as to deal with unwanted feelings. By helping others in their struggle, members feel better about themselves, which is an essential step in “self-healing.” Feeling better is crucial in combating the use of food as an “Emotional Crutch.”

While there are many weight loss apps out there, what makes this app unique is the kind of support that’s WeightLossBudddy’s stock in trade. In addition to its’ state-of-the-art Mobile App WLB offers a mirror of the App on its’ desk-top Website, so those who prefer the “big screen” need not miss a beat. It's perfect for seniors, and those on their laptops. It is the ONLY app that offers complete symmetry, where users can use both interchangeably. At home, in the office, in the car, your Buddy is there for you 24/7.

WeightLossBuddy focuses exclusively on weight loss and so attracts experts from around the world who lend their expertise. It is not unusual to see experts contribute posts to help users who are struggling.

WeightLossBuddy is 100% FREE 100% percent of the time!
Joey Dweck
Weight Loss Buddy, Inc
+1 917-841-2521

Weight Loss Buddy, Inc
Weight LOss Buddy
+1 917-841-2521
email us here
Visit us on social media:

Weight Loss Buddy

Source: EIN Presswire